EP3153170
METHODS AND USES OF THE QUINOLINE DERIVATIVE ANLOTINIB IN THE TREATMENT OF SOFT TISSUE SARCOMAS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SAME
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.6.2015EP published:
13.8.2025EP application number:
15803853.9
EPO information:
European Patent Register
Max expiry date:
4.6.2035
Title in English:
METHODS AND USES OF THE QUINOLINE DERIVATIVE ANLOTINIB IN THE TREATMENT OF SOFT TISSUE SARCOMAS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SAMELanguage of the patent:
English
Timeline
Today
5.6.2015EP application
13.8.2025EP Publication
Owner
Name:
Chia Tai Tianqing Pharmaceutical Group Co., LtdAddress:
No. 369 Yuzhou South Road Haizhou District, Lianyungang, Jiangsu 222062, CN
Name:
Advenchen Laboratories Nanjing Ltd.Address:
Room 302, Block A, Pharmaceutical & Biology Incubator Building Entrepreneurship Center Nanjing New & High Tech Zone, Nanjing, Jiangsu 210061, CN
Inventor
Name:
ZHANG, XiquanAddress:
Lianyungang Jiangsu 222062, CN
Name:
WANG, XunqiangAddress:
Lianyungang Jiangsu 222062, CN
Name:
ZHAN, XiaoleAddress:
Lianyungang Jiangsu 222062, CN
Name:
DAI, JieAddress:
Lianyungang Jiangsu 222062, CN
Name:
TIAN, XinAddress:
Lianyungang Jiangsu 222062, CN
Name:
YANG, LingAddress:
Lianyungang Jiangsu 222062, CN
Priority
Number:
201410249705Date:
6.6.2014Country:
CN
Classification
Categories:
A61K 31/4709, A61P 35/00, A61K 9/48